Johnson & Johnson (JNJ) reported $22.45 billion in revenue for the quarter ended June 2024, representing a year-over-year decline of 12.1$2.82 for the same period compares to $2.80 a year ago.The reported revenue compares to the Zacks Consensus Estimate of$22.35 billion, representing a surprise of +0.43%. The company delivered an EPS surprise of +4.06%, with the consensus EPS estimate being $2.71.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall ...